Chemical Component Summary | |
---|---|
Name | L-deoxythymidine |
Synonyms | L-thymidine; beta-L-thymidine; L-dT; 2'-deoxy-L-thymidine; 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione |
Identifiers | 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione |
Formula | C10 H14 N2 O5 |
Molecular Weight | 242.229 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O |
InChI | InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1 |
InChIKey | IQFYYKKMVGJFEH-CSMHCCOUSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 3 |
Bond Count | 32 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB01265 |
---|---|
Name | Telbivudine |
Groups |
|
Description | Telbivudine is a synthetic thymidine nucleoside analog with specific activity against the hepatitis B virus. Telbivudine is orally administered, with good tolerance, lack of toxicity and no dose-limiting side effects. |
Synonyms |
|
Brand Names |
|
Indication | For the treatment of chronic hepatitis B in adult and adolescent patients ≥16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. |
Categories |
|
ATC-Code | J05AF11 |
CAS number | 3424-98-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
DNA | - | unknown | |
Protein P | MPLSYPHFRKLLLLDDEAGPLEEELPRLADEDLNRRVAADLNLQLPNVSI... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 159269 |
ChEMBL | CHEMBL374731 |
ChEBI | CHEBI:63624 |